|Articles|July 1, 2012
- Applied Clinical Trials-07-01-2012
- Volume 21
- Issue 7
Applied Clinical Trials Digital Edition - July 2012
Regulatory: Developing Biosimilars for a Global Market Subject Recruitment: Patient Interest in Clinical Trial Referral CRO/Sponsor: Functional Service Provider Model Also in this issue: Proposed Rule Changes in Europe Global Study Monitors Benchmarks Emergency Department Trials
Advertisement
Articles in this issue
about 14 years ago
Managing Budgets in Complex Times with Tight Variancesabout 14 years ago
Act coverabout 14 years ago
Business and News Update July 2012about 14 years ago
Increasing Intensity of On-Site Monitoring a Troubling Trendabout 14 years ago
Drug Information? Forget it!about 14 years ago
Supply Chain Managementabout 14 years ago
Developing Quality Biosimilarsabout 14 years ago
Drivers of Patient Interest in Referralabout 14 years ago
Risk-Based Monitoring Risky for Sponsors?about 14 years ago
Fresh Doubts Cast Over Post-Marketing TrialsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5